GlaxoSmithKline plc’s (GSK) “Underperform” Rating Reaffirmed at BNP Paribas
BNP Paribas reiterated their underperform rating on shares of GlaxoSmithKline plc (LON:GSK) in a research report released on Friday morning. BNP Paribas currently has a GBX 1,520 ($19.84) price target on the stock.
A number of other analysts have also commented on the company. Shore Capital reaffirmed a hold rating on shares of GlaxoSmithKline plc in a research report on Wednesday, July 27th. JPMorgan Chase & Co. boosted their target price on GlaxoSmithKline plc from GBX 1,470 ($19.19) to GBX 1,800 ($23.50) and gave the company a neutral rating in a research report on Tuesday, July 12th. Goldman Sachs Group Inc. reaffirmed a buy rating and issued a GBX 1,800 ($23.50) target price on shares of GlaxoSmithKline plc in a research report on Tuesday, July 12th. Morgan Stanley boosted their target price on GlaxoSmithKline plc from GBX 1,500 ($19.58) to GBX 1,650 ($21.54) and gave the company an equal weight rating in a research report on Monday, July 11th. Finally, Citigroup Inc. reaffirmed a buy rating on shares of GlaxoSmithKline plc in a research report on Thursday, June 23rd. Three equities research analysts have rated the stock with a sell rating, sixteen have issued a hold rating and eight have issued a buy rating to the stock. The company has a consensus rating of Hold and a consensus target price of GBX 1,676.44 ($21.88).
GlaxoSmithKline plc (LON:GSK) traded up 1.13% during mid-day trading on Friday, hitting GBX 1661.50. The stock had a trading volume of 3,508,581 shares. The firm’s 50-day moving average price is GBX 1,645.84 and its 200-day moving average price is GBX 1,542.41. GlaxoSmithKline plc has a 1-year low of GBX 1,261.50 and a 1-year high of GBX 1,716.50. The stock’s market cap is GBX 80.77 billion.
The company also recently declared a dividend, which will be paid on Thursday, October 13th. Stockholders of record on Thursday, August 11th will be issued a GBX 19 ($0.25) dividend. The ex-dividend date is Thursday, August 11th. This represents a dividend yield of 1.12%.
In related news, insider Witty,Sir Andrew P sold 10,000 shares of the stock in a transaction on Wednesday, July 27th. The stock was sold at an average price of GBX 1,693 ($22.10), for a total value of £169,300 ($220,989.43). Also, insider Slaoui,Moncef bought 28 shares of GlaxoSmithKline plc stock in a transaction that occurred on Friday, August 12th. The stock was purchased at an average cost of GBX 2,208 ($28.82) per share, for a total transaction of £618.24 ($807.00).
GlaxoSmithKline plc Company Profile
GlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company’s segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare.
Receive News & Stock Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related stocks with our FREE daily email newsletter.